Mark Miranda
Internal Medicine · San Juan, PRNPI 1558996215
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.8% of the total across 120 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 10.1% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,236, more than ten times the $113 reported in 2022. Among internal medicine clinicians in PR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 120 payments — averaging $39.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$481
- Amgen$469
- PBG Puerto Rico LLC$363
- Incyte Corporation$314
- Tempus AI, Inc$288
- AstraZeneca$271
- plus $3K from 25 others
What the payments were for
- Food & beverage$4,57396%
- Education$1994%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 4 | $481 |
| Amgen | 11 | $469 |
| PBG Puerto Rico LLC | 18 | $363 |
| Incyte Corporation | 5 | $314 |
| Tempus AI, Inc | 7 | $288 |
| AstraZeneca(2 entities) | 8 | $271 |
| Adaptive Biotechnologies Corporation | 2 | $266 |
| Rigel Pharmaceuticals, Inc. | 2 | $250 |
| Taiho Oncology, Inc. | 2 | $249 |
| AbbVie | 6 | $221 |
| Johnson & Johnson | 10 | $201 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $160 |
| Genmab U.S., Inc. | 2 | $147 |
| Regeneron Healthcare Solutions, Inc. | 6 | $147 |
| Sobi, Inc | 2 | $122 |
| Novartis | 6 | $122 |
| Merck | 6 | $122 |
| Seagen Inc. | 1 | $100 |
| E.r. Squibb & Sons, L.L.C. | 3 | $73 |
| Telix Pharmaceuticals | 3 | $71 |
| Karyopharm Therapeutics Inc. | 1 | $65 |
| GSK | 2 | $43 |
| Genentech USA, Inc. | 2 | $40 |
| EMD Serono, Inc. | 1 | $37 |
| ADC Therapeutics America, Inc. | 1 | $24 |
| Bayer Puerto Rico Inc. | 1 | $23 |
| AVEO Pharmaceuticals, Inc. | 1 | $23 |
| Servier Pharmaceuticals LLC | 1 | $22 |
| Caris MPI, Inc. | 1 | $21 |
| Pfizer | 1 | $19 |
| Eisai Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,772 in reported general payments places this provider in the 90th percentile of 1,043 internal medicine providers in Puerto Rico.
Other internal medicine in San Juan
- Ricardo FernandezSan Juan$351K
- Norma SalgadoSan Juan$21K
- Victor Gordo GonzalezSan Juan$21K
- Roberto Calderon SantiagoSan Juan$20K
- Natalia Almodovar ArbeloSan Juan$9K
- Jeremy FelicianoSan Juan$8K
- Porfirio Diaz-RodriguezSan Juan$8K
- Pedro del Valle de TomasSan Juan$7K
- Rafael Figueroa NavarroSan Juan$6K
- Amilcar Torres FigueroaSan Juan$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.